Israel: Ministry of Health Supplement Notification, AMAR Medical Devices and Hebrew Labelling Discipline

The Public Health (Food)(Food Supplements) Regulations 1997 (תקנות בריאות הציבור (מזון) (תוספי מזון)) define food supplements as concentrated sources of nutrients or other substances with a nutritional or physiological effect, marketed in dose form to supplement normal diet, and govern notification, composition, labelling and claims. Pre-marketing notification with the MoH Food Service is required for each supplement SKU before placement on market — the file covers ingredient list with quantitative declaration of active substances, manufacturing site GMP evidence, finished-product specification, label artwork in Hebrew, evidence supporting claimed structure-function statements, target population, recommended daily dose with safety substantiation and country-of-origin documentation. The MoH operates positive lists for vitamins and minerals with upper daily-intake limits (broadly aligned with EU food supplements directive 2002/46 plus Israel-specific national positions) and reviews novel botanicals, amino-acid blends, probiotic strains and bioactive ingredients case-by-case. Disease-treatment, prevention and drug-like claims trigger reclassification to medicinal product (requiring marketing authorisation through the Pharmaceuticals Division — a far heavier pathway). Typical notification timeline is 30-90 working days depending on novelty; complete files for routine vitamin/mineral combinations clear faster, while novel ingredients may extend to 6+ months with expert committee review.

The Medical Devices Regulations 5772-2012 (effective 2013) created the AMAR (אגף ציוד רפואי) Medical Devices Division within the MoH and the AMAR Registry as the formal device-listing system. Devices are classified by risk (I, IIa, IIb, III mirroring the EU MDR risk tiers), and Israel accepts reference-country approvals — FDA 510(k) or PMA, EU MDR CE marking with a notified-body certificate, Health Canada licence, Japanese PMDA marketing authorisation or TGA registration — as the technical basis for AMAR registration, dramatically simplifying the dossier for products already approved in major reference markets. The application covers proof of reference-country approval, Israeli authorised representative appointment, Hebrew labelling and instructions for use, post-market surveillance plan and incident-reporting commitment. Class I devices follow a simplified declaration pathway with AMAR notification; Class IIa/IIb/III follow the full registration pathway with technical review proportionate to risk class. Registration validity is typically 5 years with renewal required. Without a valid AMAR registration the device cannot be imported, distributed or used in Israeli healthcare. Post-market obligations include incident reporting to AMAR within prescribed timelines (typically 10 working days for serious incidents), Field Safety Corrective Action (FSCA) coordination with AMAR, and annual reporting for higher-risk classes.

Hebrew is the mandatory primary labelling language for food, supplements and medical devices placed on the Israeli market, with Arabic and English supplementary text permitted (and commercially useful for the Arab Israeli market and tourist channels). Mandatory information aligns broadly with Codex and the EU FIC framework — product name, ingredient list, allergen declaration, nutrition information, net quantity, manufacturer and importer details, country of origin, manufacturing/expiry date, storage conditions, supplement-specific recommended daily dose and any notified claims, plus the prescribed supplement statement ('Not a substitute for a balanced diet' or equivalent). Kosher certification is commercially essential for >85% of the Israeli domestic market — the major certifying bodies (Chief Rabbinate of Israel, Badatz Edah HaChareidis, OU Israel, OK Israel and others) operate tiered kosher schemes (mehadrin = strictest, regular kosher, kosher for Passover with specific Passover-eligible ingredients only) that drive supplier qualification, manufacturing-line dedication or kosherisation between runs, ingredient sourcing (gelatin from kosher slaughter, dairy/parve/meat segregation), packaging-material kosher certification and seasonal Passover production planning. Halal certification serves the Arab Israeli and export-to-Muslim-market channels. Cosmetic, personal-care, supplement and food brand-owners typically maintain parallel kosher and halal supply chains with full traceability documentation back to the certifying body.

Imports clear through MoH Border Inspection (food and supplements) and AMAR import authorisation (medical devices) with documentary checks (notification or registration, certificate of free sale from country of origin or reference market, certificate of analysis, kosher certificate where claimed) plus risk-based physical inspection and sampling. The MoH Food Service operates retail surveillance with sampling against the notified specification; AMAR conducts post-market device surveillance including incident analysis and field-action coordination. Non-compliance triggers product seizure, notification or registration suspension, administrative fines and — for serious safety violations or fraud — criminal liability under the Public Health Ordinance and Medical Devices Regulations. Commercial realities include a concentrated retail landscape (Super-Pharm and Be Pharm dominate supplement/pharmacy channels; Shufersal and Rami Levy dominate grocery), strong direct-to-consumer e-commerce growth, Hebrew-only digital marketing in the domestic market, kosher-certification scrutiny as a marketing-funnel filter, and a sophisticated consumer base that values clinical substantiation, kosher tier and origin-country signalling. Reference-country approvals (FDA, EU, Health Canada) carry significant brand weight in the regulated-product categories.